SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026062
Filing Date
2021-05-10
Accepted
2021-05-10 16:16:15
Documents
59
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dsgn-10q_20210331.htm 10-Q 2090230
2 EX-31.1 dsgn-ex311_8.htm EX-31.1 20468
3 EX-32.1 dsgn-ex321_7.htm EX-32.1 11783
  Complete submission text file 0001564590-21-026062.txt   6172938

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT dsgn-20210331.xml EX-101.INS 1122781
5 XBRL TAXONOMY EXTENSION SCHEMA dsgn-20210331.xsd EX-101.SCH 51063
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dsgn-20210331_cal.xml EX-101.CAL 42423
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dsgn-20210331_def.xml EX-101.DEF 147388
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE dsgn-20210331_lab.xml EX-101.LAB 355343
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dsgn-20210331_pre.xml EX-101.PRE 269920
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40288 | Film No.: 21907421
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences